Frailty dynamics and their impact on QoL in patients undergoing autologous HCT for multiple myeloma: Results from a multicentre GETH-TC study BRIT J HAEMATOL
A phase Ib/II trial combining brentuximab vedotin with cyclophosphamide, procarbazine, prednisone, etoposide and mitoxantrone (BrEPEM) for older patients with untreated classical Hodgkin lymphoma: A multicentre GELTAMO trial BRIT J HAEMATOL
Implementation of the precision oncology program in catalonia's public health system: results, lessons learned, and future prospects Clin Transl Oncol
Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphoma
Dose escalation study of the HLA-A2-WT1 CD3 bispecific antibody RO7283420 in relapsed/refractory acute myeloid leukemia Blood Neoplasia
Patient-derived liver organoids recapitulate liver epithelial heterogeneity and enable precision modeling of alcohol-related liver disease J Hepatol
Comparative analysis of 5-year relative survival in adolescents and young adults with cancer relative to both children and adults in Europe (EUROCARE-6): Results from a population-based study Eur J Cancer
Ixazomib decreases the risk of chronic graft-versus-host disease: identification of cGvHD biomarkers Blood Adv